Li Kang Biomedical Co., Ltd. (TPEX:6242)

Taiwan · Delayed Price · Currency is TWD

33.85

0.00 (0.00%)

Oct 6, 2026, 1:21 PM CST

Market Cap	1.08B -18.0%
Revenue (ttm)	573.36M -2.9%
Net Income	76.39M -10.9%
EPS	2.38 -11.3%
Shares Out	31.81M
PE Ratio	14.22
Forward PE	n/a
Dividend	2.00 (5.91%)
Ex-Dividend Date	Jun 16, 2026

Volume	184
Open	33.90
Previous Close	33.85
Day's Range	33.85 - 33.90
52-Week Range	33.60 - 41.40
Beta	-0.13
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About Li Kang Biomedical

Li Kang Biomedical Co., Ltd. produces and sells pharmaceuticals, beauty products, and health food. It offers Chinese and Western medicines, nutritional supplements, beauty and skincare products, and daily necessities products. The company was formerly known as BAFO Technologies Corporation and changed its name to Li Kang Biomedical Co., Ltd. in September 2014. Li Kang Biomedical Co., Ltd. was founded in 1982 and is based in Tainan City, Taiwan. [Read more]

Industry Travel Services

Sector Consumer Discretionary

Founded 1982

Employees 122

Stock Exchange Taipei Exchange

Ticker Symbol 6242

Full Company Profile

Financial Performance

In 2025, Li Kang Biomedical's revenue was 589.21 million, an increase of 4.19% compared to the previous year's 565.52 million. Earnings were 83.82 million, an increase of 8.83%.

Financial Statements